Trials / Completed
CompletedNCT02231593
SAGIT for Classification of Patients With Acromegaly in Clinical Practice
Pilot Testing of SAGIT in Patients With Acromegaly in Clinical Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 71 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this pilot study is to test SAGIT (Signs and symptoms - Associated comorbidities - GH concentration level - IGF-1 - Tumour). SAGIT is a Clinician-Reported Outcomes (ClinROs) tool developed to describe patients with acromegaly. This study will determine the potential use of a finalised operational version for patient classification in clinical practice and studies. In addition, this study intends to carry out a qualitative evaluation of the acceptability of SAGIT by the practicing endocrinologist in terms of relevance, ease of use, applicability and usefulness of the tool in practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | SAGIT | SAGIT is a Clinician-Reported Outcomes (ClinROs) tool |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2014-05-01
- Completion
- 2014-05-01
- First posted
- 2014-09-04
- Last updated
- 2020-03-31
Locations
21 sites across 7 countries: United States, Brazil, France, Germany, Italy, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT02231593. Inclusion in this directory is not an endorsement.